Intended for healthcare professionals

Feature Formula Milk

Overdiagnosis and industry influence: how cow’s milk protein allergy is extending the reach of infant formula manufacturers

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5056 (Published 05 December 2018) Cite this as: BMJ 2018;363:k5056

Re: Overdiagnosis and industry influence: how cow’s milk protein allergy is extending the reach of infant formula manufacturers

The somewhat misleading RCPCH response does not address the key issue.

On-going RCPCH entangelment with formula manufacturers, justified by focussing on the promotion of so-called "specialist formulas", allows the companies to circumvent Unicef UK BFI standards on access to clinicians and enhances the company brand by association. Formula advertisements are placed prominently at conferences (including the annual RCPCH meeting) or on a full page or a back cover of a journal (including the RCPCH journal), and can achieve broad brand recognition and credibility by association with a respected professional organisation.

Competing interests: No competing interests

06 December 2018
William McGuire
Professor of Child Health
University of York
CRD